November 12, 2014
Notes: Weng, Te-I
Research Support, Non-U.S. Gov’t
World J Gastroenterol. 2013 Nov 7;19(41):7097-105. doi: 10.3748/wjg.v19.i41.7097.
Author Address: Te-I Weng, Hsiao-Yi Wu, Department of Forensic Medicine, College of Medicine, National Taiwan University, Taipei 100, Taiwan.
Reference Type: Journal Article
Record Number: 4821Author: Winny, M., Paroglou, V., Bektas, H., Kaltenborn, A., Reichert, B., Zachau, L., Kleine, M., Klempnauer, J. and Schrem, H.
Title: Insulin dependence and pancreatic enzyme replacement therapy are independent prognostic factors for long-term survival after operation for chronic pancreatitis
Short Title: Insulin dependence and pancreatic enzyme replacement therapy are independent prognostic factors for long-term survival after operation for chronic pancreatitis
Alternate Journal: Surgery
ISSN: 1532-7361 (Electronic)
Accession Number: 24287147
*Enzyme Replacement Therapy
Quality of Life
Abstract: BACKGROUND: This retrospective, single-center, observational study on postoperative long-term results aims to define yet unknown factors for long-term outcome after operation for chronic pancreatitis. PATIENTS AND METHODS: We analyzed 147 consecutive patients operated for chronic pancreatitis from 2000 to 2011. Mean follow-up was 5.3 years (range, 1 month to 12.7 years). Complete long-term survival data were provided by the German citizen registration authorities for all patients. A quality-of-life questionnaire was sent to surviving patients after a mean follow-up of 5.7 years. RESULTS: Surgical principles were resection (n = 86; 59%), decompression (n = 29; 20%), and hybrid procedures (n = 32; 21%). No significant influences of different surgical principles and operative procedures on survival, long-term quality of life and pain control could be detected. Overall 30-day mortality was 2.7%, 1-year survival 95.9%, and 3-year survival 90.8%. Multivariate Cox regression analysis revealed that only postoperative insulin dependence at the time of hospital discharge (P = .027; Exp(B) = 2.111; 95% confidence interval [CI], 1.089-4.090) and the absence of pancreas enzyme replacement therapy at the time of hospital discharge (P = .039; Exp(B) = 2.102; 95% CI, 1.037-4.262) were significant, independent risk factors for survival with significant hazard ratios for long-term survival. Long-term improvement in quality of life was reported by 55 of 76 long-term survivors (73%). CONCLUSION: Pancreatic enzyme replacement should be standard treatment after surgery for chronic pancreatitis at the time of hospital discharge, even when no clinical signs of exocrine pancreatic failure exist. This study underlines the potential importance of early operative intervention in chronic pancreatitis before irreversible endocrine dysfunction is present.